Effect of Midwife Administration of Hyoscine-Butylbromide in Preventing Prolonged Labour among Primigravidal Women in Ogbomoso Oyo-State, Nigeria

Abstract

Prolonged labour increases risk of maternal fatigue, postpartum haemorrhage, sepsis, and
fetal distress. Therefore, proactive midwife intervention aiming at preventing prolonged
labour actively by administering hyoscine-butylbromide (buscopan injection) an
antispasmodic agent at the active phase of labour is of great importance for women and
most importantly primigravidal woman in labour who is at higher risk of prolonged labour.
This study investigates effect of midwife administration of hyoscine-butylbromide in
preventing prolonged labour among primigravidal women in selected health facilities in
Ogbomosho, Oyo State, Nigeria. A double blind quasi experimental research design was
adopted in this study involving sixty (60) primigravidal women in labour. Thirty (30) of
which were the experimental group and 30 were control group. A self-designed checklist
was used to assess the duration of labour stages and outcomes; while midwife is providing
care to the woman in labour. Inferential statistics such as Pearson correlation was used to
test the hypotheses at a significance level of 0.05. The study revealed a significant
difference in the administration of hyoscine-butylbromide on the duration of labour
between the experimental and control groups P-value 0.023. However, there was no
significant difference in labour outcomes between groups, P- Value 0.692. It is therefore
recommended that Hyoscine-butylbromide should be included among drugs administered
by midwives, as it has no adverse effects on the mother or fetus and does not significantly
affect the outcome of labour. Thus, hyoscine-butylbromide should be considered a
recommendation for primigravidal women during the active phase of labour to proactively
prevent prolonged labour.